Deerfield Beach, FL -- (SBWIRE) -- 10/16/2017 -- According to the report, the global demand for metabolomics was valued at over USD 675.0 million in 2015 and it is expected to reach above USD 2,500.0 million in 2021, growing at a CAGR of above 25.0% between 2016 and 2021. Zion Market Research has published a new report titled "Metabolomics Market by Technology (Mass Spectrometry, Capillary Electrophoresis, High Performance Liquid Chromatography, Gas Chromatography, and Nuclear Magnetic Resonance Spectroscopy), Indication (Cardiology and Oncology) for Drug Discovery, Biomarker and Nutrigenomics : Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021".

Metabolism is the chemical reaction in the cell or tissue to maintain the living state of the cell. Metabolism can be either anabolism or catabolism. Anabolism is the process in which compounds are synthesized that is required for cells to process, while the breakdown of molecules for releasing energy is the catabolism. The metabolome is the set of metabolites like signaling molecules, hormones metabolic intermediates and secondary metabolites, present in a single organism. Metabolomics is a study of chemical reactions related to metabolites and a field of analytical biochemistry.Metabolomics is used to quantify and identify the metabolites present in the cell by using the analytical technologies coupled with a multi-variant and statistical method for data interpretation.

Request For Free Sample Report: https://goo.gl/G9pDP2

Development of metabolomics data analysis software and biomarker screening of diseases metabolomics is used as diagnostic tool contributes to the splendid growth of metabolomics market. Moreover increasing the scope of toxicological studies, clinical trials, rise in awareness for health and government and institution funds for research drives the demand for the metabolomics market. Validation of the process and lack of adoption of metabolomics technology is the major restraint of the metabolomics market. Untapped demand from emerging economies and surging research and development expenditure are likely to open new market avenues in the near future.

The metabolomics market is segmented on basis of technology, indication, application, and region.Mass spectrometry, capillary electrophoresis, high-performance liquid chromatography, gas chromatography, and nuclear magnetic resonance spectroscopy are the technologies for metabolomics market.

Request For Free Price Quotation: http://www.marketresearchstore.com/requestquote?reportid=55501

The high-performance liquid chromatography segment accounted the highest share of metabolomics market. Applications include drug discovery, biomarker, and nutrigenomics. Drug discovery emerged as potential segment owing to its important role in optimization, prioritization, and drug target validation and identification for research. Cardiology and oncology are the indications for metabolomics.

With over 40%shares in total, metabolomics market was dominated by North America in 2015. This region is expected to be the fastest-growing market in near future. Europe was the second largest market for metabolomics in 2015. Asia Pacific is expected to witness rapid CAGR during the forecast period. The key players for the metabolomics market include Danaher Corporation, Bruker Corporation, Waters Corporation, Metabolon, Inc., Agilent Technologies, Thermo Fisher Scientific and Shimadzu Corporation among others.

Browse the full report at: http://www.marketresearchstore.com/report/metabolomics-market-z55501

Key players in global metabolomics market include Danaher Corporation, Bruker Corporation, Waters Corporation, Metabolon, Inc., Agilent Technologies, Thermo Fisher Scientific and Shimadzu Corporation among others.